MedPath

ANGIOCRINE BIOSCIENCE

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:2

Trial Phases

2 Phases

Phase 1:2
Phase 3:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)โ€ข Click on a phase to view related trials

Phase 1
2 (66.7%)
Phase 3
1 (33.3%)

A Study of the Effects of AB-205 in Patients With Lymphoma Undergoing Autologous Hematopoietic Cell Transplantation

Phase 3
Terminated
Conditions
Non Hodgkin Lymphoma
Hodgkin Lymphoma
Interventions
Other: Placebo
First Posted Date
2022-01-06
Last Posted Date
2025-02-04
Lead Sponsor
Angiocrine Bioscience
Target Recruit Count
130
Registration Number
NCT05181540
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Banner MD Anderson Cancer Center, Gilbert, Arizona, United States

๐Ÿ‡บ๐Ÿ‡ธ

City of Hope Comprehensive Cancer Center, Duarte, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

University of California, Los Angeles, Los Angeles, California, United States

and more 25 locations

Trial of AB-205 in Adults With Lymphoma Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation

Phase 1
Completed
Conditions
Hodgkin Lymphoma
Non-hodgkin Lymphoma
First Posted Date
2019-04-24
Last Posted Date
2022-03-03
Lead Sponsor
Angiocrine Bioscience
Target Recruit Count
42
Registration Number
NCT03925935
Locations
๐Ÿ‡บ๐Ÿ‡ธ

City of Hope Comprehensive Cancer Center, Duarte, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

UC Davis Comprehensive Cancer Center, Sacramento, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

UC San Diego Moores Cancer Center, San Diego, California, United States

and more 6 locations

Trial of AB-110 in Adults With Hematologic Malignancies Undergoing Cord Blood Transplantation

Phase 1
Completed
Conditions
Myelodysplastic Syndromes
Acute Myeloid Leukemia
Acute Lymphoblastic Leukemia in Remission
Other Acute Leukemias
First Posted Date
2018-03-30
Last Posted Date
2022-05-31
Lead Sponsor
Angiocrine Bioscience
Target Recruit Count
10
Registration Number
NCT03483324
Locations
๐Ÿ‡บ๐Ÿ‡ธ

City of Hope Comprehensive Cancer Center, Duarte, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

University of Colorado Cancer Center University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States

๐Ÿ‡บ๐Ÿ‡ธ

Memorial Sloan Kettering Cancer Center, New York, New York, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

ยฉ 2025 MedPath, Inc. All rights reserved.